Mike Busch, MD, PhD (he/him/his)

Director Emeritus
Vitalant Research Institute
San Francisco, California, United States

Presentation(s):

• AM24-ST-26-L - Oral Abstract - COVID

  Saturday, October 19, 2024
  1:45 PM - 2:45 PM  

  Disclosure(s): Abbott: Stock Shareholder (self-managed) (Ongoing); Grifols Diagnostic Solutions: Grant/Research Support (Ongoing); Hologic: Grant/Research Support (Ongoing); International Society of Blood Transfusion: Consultant/Advisory Board (Ongoing), Immediate Past Present; Board of Directors (Ongoing); QuidelOrtho: Grant/Research Support (Terminated); Vitalant: Full-time/Part-time Employee or Owner (Ongoing)

• AM24-MN-05-L - Donor and Recipient Safety and Transfusion Efficacy Research: Past, Present and Future (Presented by Michael Busch, Landsteiner-Alter Award Recipient)

  Monday, October 21, 2024
  8:15 AM - 9:15 AM  

  Disclosure(s): Abbott: Stock Shareholder (self-managed) (Ongoing); Grifols Diagnostic Solutions: Grant/Research Support (Ongoing); Hologic: Grant/Research Support (Ongoing); International Society of Blood Transfusion: Consultant/Advisory Board (Ongoing), Immediate Past Present; Board of Directors (Ongoing); QuidelOrtho: Grant/Research Support (Terminated); Vitalant: Full-time/Part-time Employee or Owner (Ongoing)